Expansion of securities systems services centered on SENS21
First written in FY2018. 16 of 25 entries say "Advanced", first in FY2019-Q1. Latest entry: 2026-07-29.
The whole theme swung hardest in 2018: 1 of 9 companies on the "Worse" side.
10 other companies' latest entry also says "Advanced".
- 2026-07-29AdvancedEarnings
「Although sales increased from development projects in the securities business,」
Development projects in the securities business contributed to higher first-quarter sales, confirming the contribution of securities-system service projects. - FY2026AdvancedAnnual report
「For securities and JASDEC operations for securities companies, revenue was ¥1,277.232 million, up 9.7% year on year, due mainly to revenue from WITH-X®-related development projects.」
Revenue from securities and JASDEC operations was ¥1,277.232 million, up 9.7% year on year, with WITH-X®-related development projects contributing to the increase. - FY2025AdvancedAnnual report
「In the securities operations business, the Company reached a basic agreement to collaborate with 株式会社東証コンピュータシステム, which has an extensive track record, strong credibility and advanced technical capabilities. The two companies will leverage their respective strengths to commercialize a total solution covering operations from the front office through the back office and contribute to improving the efficiency and optimization of operations at securities companies and other financial institutions.」
The business progressed from expanding individual securities systems services to developing a total solution covering the front office through the back office through collaboration with 東証コンピュータシステム. - FY2025-H1AdvancedAnnual report
「In terms of performance, revenue was ¥2,108.261 million, up 9.0% year on year, due mainly to revenue from WITH-X®-related projects implemented in response to system revisions in the securities operations business in the previous fiscal year contributing to the current fiscal year, as well as development of a core clinical laboratory testing system in the healthcare-related services business.」
In securities systems services, WITH-X®-related revenue from development projects implemented in response to system revisions contributed to the current fiscal year and, together with healthcare-related services, was a factor behind the increase in revenue. - FY2024AdvancedAnnual report
「For securities and JASDEC operations for securities companies, revenue was ¥1,106.293 million, up 5.4% year on year, due mainly to increased revenue from the comprehensive securities system WITH-X® and demand for system improvements associated with revisions to systems such as the new NISA framework.」
In securities systems services, revenue from securities and JASDEC operations was ¥1,106.293 million, up 5.4% year on year, due to increased WITH-X® revenue and demand for system improvements associated with revisions to systems such as the new NISA framework. - FY2024-Q3AdvancedAnnual report
「In terms of performance, revenue was ¥3,195.074 million, up 3.4% year on year, due mainly to increased revenue from the securities operations services WITH-X® (With Cross) (Note 4) and KIZUNA-X® (Kizuna Cross) (Note 5), development of a clinical laboratory testing system, and an increase in maintenance support projects at subsidiaries.」
Increased revenue from WITH-X® and KIZUNA-X® in securities operations contributed to performance, and expansion through deeper transactions with existing customers of securities systems services continued. - FY2024-Q2AdvancedAnnual report
「In terms of performance, revenue was ¥1,935.058 million, up 3.4% year on year, due mainly to increased revenue from the securities operations services WITH-X® and KIZUNA-X® (Kizuna Cross) (Note 3), as well as deeper transactions with existing customers of subsidiary エフプラス.」
WITH-X® and KIZUNA-X® in the SAKIX series, together with deeper transactions with existing customers of subsidiary エフプラス, contributed to revenue growth, and the contribution of securities systems services to performance was described. - FY2024-Q1AdvancedAnnual report
「<System development and maintenance> Sales were ¥47.444 million, up 43.1% year on year, due mainly to development related to KIZUNA-X in the SAKIX series for securities operations.」
For the SAKIX series, which was reorganized from SENS21, KIZUNA-X-related development contributed to revenue, indicating specific progress in the development side of securities systems services. - FY2023ReframedAnnual report
「The securities trading solution was renewed under the SAKIX (Sakigake) brand.」
The securities trading solution, formerly centered on SENS21 as part of the securities systems services business, was reorganized under the SAKIX brand. - FY2023-Q1Revenue decline due to the loss of development projectsAnnual report
「<System development and maintenance> Sales were ¥33.152 million, down 51.5% year on year, due mainly to the absence of My Number-related system development in securities operations and system development for Gakken Group companies.」
Development projects for securities operations and companies in the Gakken Group were lost, causing system development and maintenance revenue to fall 51.5% year on year. - FY2022Revenue growth in securities and JASDEC operations alongside the loss of development projectsAnnual report
「For securities and JASDEC operations for securities companies, revenue was ¥1,079.034 billion, up 4.6% year on year, despite the loss of a server replacement development project, due to an increase in My Number operations and other factors.」
Although server replacement development projects were lost, revenue from securities and JASDEC operations increased due mainly to growth in My Number operations and other factors. - FY2022-Q3Loss of server replacement development projectsAnnual report
「<System development and maintenance> Sales were ¥149.909 million, down 23.0% year on year, despite My Number-related system development in securities operations and system development for Gakken Group companies, due mainly to the absence of server replacement development projects in securities operations and application development projects for tablets used with medical systems.」
In the securities systems business, system development and maintenance revenue fell 23.0% year on year due to the loss of server replacement development projects. - FY2021AdvancedAnnual report
「For securities and JASDEC operations for securities companies, revenue was ¥1,031.198 million, up 5.0% year on year, due mainly to JASDEC server replacement development projects and other factors.」
Revenue from securities and JASDEC operations was ¥1,031.198 million, up 5.0% year on year, due mainly to JASDEC server replacement development projects and other factors. - FY2021-Q3AdvancedAnnual report
「<System development and maintenance> Sales were ¥194.767 million, up 0.9% year on year, due mainly to server replacement development projects in securities operations, despite a decline in application development for tablets used with medical systems.」
Server replacement development projects in securities operations and other projects were recorded, indicating new progress in securities systems development projects. - FY2021-Q1Loss of unfair trading monitoring system development projectsAnnual report
「<System development and maintenance> Sales were ¥48.731 million, down 10.8% year on year, despite a server replacement development project related to the clinical business, due mainly to the absence of development projects for the market surveillance system in securities operations.」
In the securities systems business, system development and maintenance revenue fell 10.8% year on year due to the loss of development projects for the unfair trading monitoring system and other factors. - FY2020Revenue decline continues following the loss of SENS21 development projectsAnnual report
「[System development and maintenance] Sales were ¥303.919 million, down 40.4% year on year, due mainly to the absence of system development related to the clinical business and development projects for the securities comprehensive system SENS21.」
System development and maintenance revenue fell 40.4% year on year due to the loss of SENS21 development projects and other factors, and development-related revenue for SENS21 continued to decline. - FY2020-Q3Revenue decline continues following the loss of SENS21 development projectsAnnual report
「<System development and maintenance> Sales were ¥192.944 million, down 50.0% year on year, due mainly to the absence of development projects for the securities comprehensive system SENS21.」
For SENS21, system development and maintenance revenue fell 50.0% year on year due to the loss of development projects, and the decline in development-related revenue has continued despite the previous expansion of operations. - FY2020-Q2Decline in development for SENS21 usersAnnual report
「<System development and maintenance> Sales were ¥124.020 million, down 15.8% year on year, despite system development related to the clinical business, due mainly to the absence of development work for users of the securities comprehensive system SENS21.」
For SENS21, system development and maintenance revenue fell 15.8% year on year due to the decline in development for users, marking a change in the pace of expansion. - FY2019AdvancedAnnual report
「For services provided to securities companies, the Company positions the unfair trading monitoring system Watch21 and the JASDEC system as ancillary systems alongside the comprehensive securities system SENS21, promotes the standardization of common infrastructure and the development of its operating structure, and will provide more effective proposals.」
In addition to SENS21, the Company positioned Watch21 and the JASDEC system as ancillary systems and indicated that it would strengthen its proposal capabilities through standardizing common infrastructure and developing its operating structure. With a new SENS21 user commencing operations, revenue from securities and JASDEC operations was ¥1,370.633 million, up 12.4% year on year. - FY2019-Q3AdvancedAnnual report
「＜System Operations＞ Revenue amounted to ¥1,737.709 million, up 13.5% year on year, due to the launch of operations for new users of the SENS21 integrated securities system and support for electronic medical record implementation.」
For SENS21, system operations revenue, including operations commenced by a new user, was ¥1,737.709 million, up 13.5% year on year. - FY2019-Q2AdvancedAnnual report
「＜System Operations＞ Revenue amounted to ¥972.604 million, up 13.8% year on year, due to the launch of operations for new users of the SENS21 integrated securities system and support for electronic medical record implementation.」
For SENS21, system operations revenue after the start of operations by a new user was ¥972.604 million, up 13.8% year on year. - FY2019-Q1AdvancedAnnual report
「For the first quarter of the current fiscal year, consolidated revenue was ¥589.101 million, up 11.8% year on year, reflecting the start of operations for new users of the SENS21 securities comprehensive system, an increase in the number of My Number operations handled, and various systems development projects.」
For SENS21, for which the start of provision was reported in FY2018, the Company described progress to the specific operational stage of a new user commencing operations. - FY2018First statedAnnual report
「The Company also began providing the comprehensive securities system SENS21 to 株式会社DMM.com証券. Drawing on its strengths in securities operations knowledge and technical expertise, the Company will support 株式会社DMM.com証券 as it newly enters the securities trading business.」
The start of providing SENS21 to 株式会社DMM.com証券 was described independently for the first time as a specific initiative involving the introduction of a securities system for a new customer and the use of securities operations expertise.